Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4

This publication has 25 references indexed in Scilit:

• Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population
  Blood, 2003
• Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMTP140K into hematopoietic stem cells
  Cancer Gene Therapy, 2002
• Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
  New England Journal of Medicine, 2002
• Genetic Chemoprotection with Mutant O6-Alkylguanine-DNA-Alkyltransferases
  Current Gene Therapy, 2002
• Gene therapy of severe combined immunodeficiencies
  The Journal of Gene Medicine, 2001
• Limiting numbers of G156A O6-methylguanine–DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection
  Blood, 2000
• Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
  Science, 2000
• O6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts
  International Journal of Cancer, 2000
• Enhanced In Vivo Regenerative Potential of HOXB4-Transduced Hematopoietic Stem Cells With Regulation of Their Pool Size
  Blood, 1999
• Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.
  Proceedings of the National Academy of Sciences, 1990